Matthews, Philippa C;
Ocama, Ponsiano;
Wang, Su;
El-Sayed, Manal;
Turkova, Anna;
Ford, Deborah;
Torimiro, Judith;
... Hamid, Saeed; + view all
(2023)
Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk.
JHEP Reports
, 5
(11)
, Article 100875. 10.1016/j.jhepr.2023.100875.
Preview |
Text
1-s2.0-S2589555923002069-main.pdf - Published Version Download (378kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Enhancement of HBV PMTCT is required because the status quo fails to protect those at highest risk |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.jhepr.2023.100875 |
| Publisher version: | https://doi.org/10.1016/j.jhepr.2023.100875 |
| Language: | English |
| Additional information: | This is an open access article under the CC BY-NC-ND license https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10178821 |
Archive Staff Only
 |
View Item |
